2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

The Trembling Descent: Down the Stairs Dystonia in Galactosemia

D. Menghani, R. Vasireddy, Z. Guduru (Lexington, USA)
The Unique Clinical Profile of Dystonia in Parkinson Disease

L. Xavier, A. Eid, H. Hwang, J. Perlmutter, P. Kotzbauer, M. Campbell, S. Norris (Saint Louis, USA)
The Unlikely Treatable A Case of Ataxia

V. Quintana, S. Bonilla, L. Carvajal, J. Nastasi Catanese, . , . (Cali, Colombia)
The use of interleaving stimulation as an advanced DBS programming strategy in movement disorders

R. Burke, P. Graese, P. Zeilman, J. Wong (Gainesville, USA)
The value of PET imaging in Parkinson’s disease with cognition impairment

T. Hu, Y. Tang, J. Wang (Shanghai, China)
The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia

L. O'Flynn, A. Domingo, A. Hamzehei Sichani, A. Nishiyama, M. Hincher, R. Yadav, L. Ozelius, K. Simonyan (Boston, USA)
Therapeutic Effect and Mechanism of Targeted Nano-selenium in Mouse Model of Parkinson’s Disease Induced by MPTP

W. Bi, L. Zhu, T. Chen, Y. Cen, J. Zou, Z. Su (Guangzhou, China)
Therapeutic Efficacy of Human Dental Pulp Stem Cells-Derived Exosome-Encased Phloroglucinol In MPTP-Induced Chronic Parkinsonian Rat model: Potential for Disease Modification

I. Datta, K. Mondal, R. Ghanty, G. Wagmare, A. Mahadevan, R. Santhoshkumar, N. Bn (Bengaluru, India)
Therapeutic Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Badran, M. Gbreel (Cairo, Egypt)
Theta and Beta Oscillations Track Happiness and Surprise in the Subthalamic Nucleus After Reward Outcome

S. Brener, G. Feng, C. Merrick, B. Blain, R. Rutledge, S. Little (New Haven, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z